BioClinica

JLL Partners to acquire BioClinica and CoreLab Partners

Wednesday, January 30, 2013 11:36 AM

BioClinica, a global provider of clinical trial management solutions, has entered into a definitive agreement to be acquired by a holding company controlled by JLL Partners, a private equity firm.

More... »

Sanofi selects Bioclinca’s Onpoint as enterprise CTMS

Monday, October 1, 2012 02:15 PM

Pharmaceutical company Sanofi has selected global provider of clinical trial management services BioClinica’s OnPoint as the company’s standard clinical trial management system (CTMS). With this decision, Sanofi plans to utilize OnPoint CTMS for all clinical trial management activity.

More... »

BioClinica, Mirada partner for molecular image analysis

Monday, April 2, 2012 06:35 AM

Through a newly formed partnership, BioClinica, a global provider of clinical trial management solutions, will integrate Oxford-based Mirada Medical's XD3 software solution into its imaging core lab technology to enhance its PET capabilities and expertise for molecular imaging trials.

More... »

BioClinica, NextDocs to streamline trial submission process

Saturday, March 24, 2012 03:58 AM

BioClinica, a global provider of clinical trial management solutions, has partnered with NextDocs, a global provider of compliance solutions, to deliver solutions for easier access to clinical trial information and decrease the timeline for FDA submissions.

More... »

Onconova extends agreement with BioClinica

Wednesday, November 30, 2011 02:54 PM

More... »

BioClinica inks seven with Trident IWR

Monday, April 18, 2011 11:55 AM

Pennsylvania-based BioClinica, a provider of clinical trial management solutions, has been selected by seven new clients for the use of BioClinica’s Trident IWR (interactive web response) to help build and deploy clinical trials without the need for programming.

More... »

BioClinica stockholder calls for executives to resign, as CEO says new eclinical push still ramping up

Tuesday, October 26, 2010 09:06 AM

White-hot controversy has been brewing between the imaging-focused CRO/eclinical company BioClinica and one of its investors, Nicusa Capital.

More... »

BioClinica Reports Flat Earnings, Adjusts 2010 EPS Guidance

Wednesday, May 5, 2010 01:07 PM

BioClinica’s first quarter 2010 earnings were flat compared with the same period 2009, with service revenues of $14.7 million. First quarter revenues last year were $14.5 million. Net income was $711,000, or $0.05 per diluted share, compared with $786,000, or $0.05 per diluted share for Q1 2009.

More... »

Oracle to Acquire Phase Forward for $685M

Friday, April 16, 2010 02:37 PM

Business software giant Oracle, already a player in the eClinical space, plans to acquire market leader Phase Forward in a deal valued at approximately $685 million—or $17 per share in cash.

More... »

BioClinica Buys TranSenda, Adds CTMS to Service Offerings

Monday, April 5, 2010 06:52 AM

BioClinica continued to grow its burgeoning eClinical division with the acquisition of clinical trial management software (CTMS) company TranSenda for an estimated $2.5 million.

More... »